NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-198-2012-0-US-08 Mesothelin Domain-Specific Monoclonal Antibodies and Use Thereof US DIV 15/141,006 9803022 Issued PDF
NIAID E-140-2015-0-PCT-02 COMPOSITIONS AND METHODS FOR DETECTING LOA LOA PCT PCT PCT/US2016/029673 Expired
NCI E-029-2006-1-US-01 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment US CIP 15/139,986 9796753 Issued PDF
NHGRI E-275-2015-0-PCT-02 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC PCT PCT PCT/US2016/029512 Expired
NIDA E-049-2015-0-PCT-02 Method and System for a Mobile Health Platform PCT PCT PCT/US2016/029553 Expired
NIDA E-049-2015-0-CA-03 Method and System for a Mobile Health Platform CA National Stage 2989281 Abandoned
NHLBI E-125-2015-0-PCT-02 Method for the Selective Depletion of Alloreactive T Lymphocytes From Donor Stem Cell or Lymphocyte Grafts to Prevent Graft-Versus-Host Disease PCT PCT PCT/US2016/029333 Expired
NCI E-153-2016-0-US-01 Anti-KK-LC-1 T Cell Receptors US 62/327,529 Abandoned
NIAID E-124-2016-0-US-01 Bivalent Immunogenic Conjugate for Malaria and Typhoid US 62/327,184 Abandoned
NHLBI E-124-2014-5-US-01 Devices and Methods For Closure Of Transvascular Or Transcameral Access Ports US 62/326,710 Expired
NCI E-520-2013-0-JP-06 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use JP National Stage 2016-525904 Issued
NCI E-520-2013-0-US-07 HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein and Compositions and Methods of Use US National Stage 15/031,435 10035832 Issued PDF
NHGRI E-090-2015-0-PCT-02 Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Therapy PCT PCT PCT/US2016/028974 Expired
NHGRI E-090-2015-0-EP-03 Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Therapy EP National Stage 16758309.5 Abandoned
NHLBI E-284-2015-1-US-01 SEGMENTED MRI CATHETERS US 62/326,613 Abandoned
NCI E-019-2014-2-US-02 COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT US National Stage 15/031,232 10464970 Issued PDF
NINDS E-101-2012-1-HK-23 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS HK National Stage 16104626.6 Abandoned
NIDDK E-138-2017-0-US-01 Compounds And Methods For Treating Brain Injury US 62/325,860 Abandoned
NCI E-048-2016-0-US-01 Irreversible Allosteric Inhibitors Of Ubiquitin-conjugating Enzyme Ube2g2 Useful As Anti-metastatic Agents US 62/325,610 Abandoned
NCI E-273-2002-0-US-06 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US CON 15/133,781 Abandoned
NCI E-131-2016-0-US-01 Evaluation Of Mantle Cell Lymphoma and Methods Related Thereto US 62/325,213 Abandoned
NHLBI E-018-2014-0-US-04 ATRIAL APPENDAGE LIGATION US National Stage 15/030,574 10575851 Issued PDF
NCATS E-072-2015-0-CN-08 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA CN National Stage 201480057514.9 Issued
NCI E-269-2010-0-US-10 Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use US CON 15/132,863 10143724 Issued PDF
NIAID E-449-2013-1-US-05 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING US National Stage 15/030,554 9968693 Issued PDF
NIAID E-292-2010-2-US-04 NOVEL HIV -1 BROADLY NEUTRALIZING ANTIBODIES US CON 15/132,406 9796774 Issued PDF
NIAID E-099-2016-0-US-01 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US 62/324,762 Abandoned
NCI E-247-2016-0-US-01 A Method To Identify Replication Fork Instability From Whole Genome Sequencing Data US 62/324,230 Abandoned
NCI E-157-2016-0-US-01 New, More Stable Immunotoxin Variants With A Disulfide Bond Protecting The Furin Cleavage Site US 62/323,668 Abandoned
NCI E-190-2014-0-KR-09 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		KR National Stage 10-2016-7009889 Issued
NICHD E-151-2015-0-PCT-02 Methods of Treating or Preventing Demyelination Using Thrombin Inhibitors and Methods of Detecting Demyelination Using Neurofascin 155 PCT PCT PCT/US2016/027776 Expired
NIAID E-256-2015-1-US-01 Modified Anthrax Toxin Protective Antigen US 62/323,218 Abandoned
NCI E-771-2013-4-RU-13 Modified Pseudomonas Exotoxin A RU National Stage 2016114406 Issued
NINDS E-146-2016-0-US-01 Selective D3 Dopamine Receptor Agonists and Methods of Their Use US 62/322,361 Abandoned
NCI E-072-2014-0-CA-04 COMPOUNDS FOR TREATING CANCER AND DIABETES CA National Stage 2982564 Issued
NCI E-072-2014-0-AU-03 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AU National Stage 2016247920 Issued
NCI E-072-2014-0-JP-06 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES JP National Stage 2017-554513 Issued
NCI E-072-2014-0-IT-15 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER IT EP 16718144.5 Issued
NCI E-072-2014-0-NO-16 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER NO EP 16718144.5 Issued
NCI E-072-2014-0-GB-14 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER GB EP 16718144.5 Issued
NCI E-072-2014-0-CH-09 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER CH EP 16718144.5 Issued
NCI E-072-2014-0-ES-12 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER ES EP 16718144.5 Issued
NCI E-072-2014-0-SE-17 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER SE EP 16718144.5 Issued
NCI E-072-2014-0-BE-08 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER BE EP 16718144.5 Issued
NCI E-072-2014-0-FR-13 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER FR EP 16718144.5 Issued
NCI E-072-2014-0-DE-10 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER DE EP 16718144.5 Issued
NCI E-072-2014-0-DK-11 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER DK EP 16718144.5 Issued
NCI E-072-2014-0-EP-05 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER EP National Stage 16718144.5 Issued
NCI E-072-2014-0-US-07 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES US National Stage 15/564,353 10287297 Issued PDF
NCI E-072-2014-0-PCT-02 EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES PCT PCT PCT/US2016/027262 Expired